Inicio › Miastenia grave › Texas
Ensayos clínicos de Miastenia grave en Texas
18 estudios sobre Miastenia grave buscan participantes en Texas.
Ciudades en Texas
Texto oficial del estudio (inglés)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Austin Neuromuscular Center, Austin
- Texas Neurology, Dallas
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Houston
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07647510ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07673627ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07284420Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Baylor Scott & White Research Institute - Baylor Scott & White Research Institute, Dallas
- ANESC Research, El Paso
- Baylor Scott & White Neurology - McKinney, McKinney
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- Nerve and Muscle Center of Texas - Neurology, Houston
- Texas Institute for Neurological Disorders, Sherman
- Neurology Care Clinic, Waxahachie
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07501702A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Austin Neuromuscular Center, Austin
ReclutandoFase 2
Edades de 2 a 17 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06987539RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 13 ago 2026 · NCT06359041Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Houston
ReclutandoFase 1/2
Edades de 18 a 85 · Todos los sexos · Actualizado el 3 ago 2026 · NCT07596901Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1003, Dallas
- Site Number - 1047, Denton
- Site Number - 1057, Houston
- y 1 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 jul 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Houston Methodist Hospital, Houston
ReclutandoFase 2/3
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06193889A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of Texas Southwestern Medical Center, Dallas
- Houston Methodist Neurological Institute, Houston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 jun 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- UT Southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 feb 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- National Neuromuscular Research Institute, Austin
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT06298565A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- Nerve & Muscle Center of Texas, Houston
- Houston Methodist Neurological Institute, Houston
ReclutandoFase 1/2
Edades de 18 a 74 · Todos los sexos · Actualizado el 11 feb 2026 · NCT07250750Vitaccess Real MG Registry
- University of Texas Health Science Center at Houston, Houston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2025 · NCT06064461De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.